AQR Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
42,910
+19,350
| +82% | +$184K | ﹤0.01% | 2718 |
|
|
2025
Q1 | $246K | Buy |
+23,560
| New | +$246K | ﹤0.01% | 2781 |
|
|
2024
Q4 | – | Sell |
-89,198
| Closed | -$3.2M | – | 2891 |
|
|
2024
Q3 | $3.2M | Buy |
89,198
+80,703
| +950% | +$2.9M | ﹤0.01% | 1262 |
|
|
2024
Q2 | $300K | Buy |
8,495
+352
| +4% | +$12.4K | ﹤0.01% | 2268 |
|
|
2024
Q1 | $231K | Buy |
+8,143
| New | +$231K | ﹤0.01% | 2219 |
|
|
2023
Q4 | – | Sell |
-11,644
| Closed | -$104K | – | 2354 |
|
|
2023
Q3 | $104K | Sell |
11,644
-8,525
| -42% | -$76.4K | ﹤0.01% | 2226 |
|
|
2023
Q2 | $227K | Buy |
+20,169
| New | +$227K | ﹤0.01% | 2047 |
|